Last edition
News about "biopharma"
Biologos Appoints Hetal Patel as Chief Executive Officer
Biologos, a leading ISO 13485–certified and GMP-compliant manufacturer of custom sterile-filtered liquid solutions, announced the appointment of Hetal Patel as chief executive officer.
Biopharma | 07/03/2026 | By Darshana | 104
Worldwide Clinical Trials Completes Acquisition of Oncology-Focused CRO Catalyst Clinical Research
Worldwide Clinical Trials strengthens its oncology and early-phase research capabilities following the completion of its acquisition of Catalyst Clinical Research.
Biopharma | 17/02/2026 | By News Bureau | 160
Indegene Acquires BioPharm for USD 106 Million to Bolster AI-Driven Pharma Marketing
This deal strengthens Indegene’s commercial capabilities by combining its data, analytics and AI platforms with BioPharm’s expertise in omnichannel marketing, media strategy and precision engagement with healthcare providers.
BioPharma | 03/10/2025 | By Darshana | 314
DHL Group Acquires CRYOPDP from Cryoport to Boost DHL Health Logistics
Going forward, DHL Supply Chain will further build the potential of its Pharma Specialized Network solution by leveraging the specialty courier expertise of newly acquired CRYOPDP and the global air capabilities of DHL Express and DHL Global Forwarding.
Biopharma | 05/04/2025 | By Aishwarya | 295
Limula Rolls Out LimONE for Seamless Workflow in Cell Therapy Manufacturing
LimONE is designed for both hospitals and biopharma companies alike, providing a versatile tool that supports the production of multiple types of cell therapy, including CAR-T and gene-edited hematopoietic stem cells.
Biopharma | 07/03/2025 | By Aishwarya | 550
Two ImmunoINSIGHTS contracts signed by Oncimmune
Oncimmune Holdings announces the signing of two new ImmunoINSIGHTS commercial contracts.
Biopharma | 15/04/2022 | By Sudeep Soparkar | 710
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy